Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. Georgakopoulou (Athens, Greece), K. Mantzouranis (Athens, Greece), D. Melemeni (Athens, Greece), G. Petsinis (Athens, Greece), D. Mermigkis (Athens, Greece), A. Lekkakou (Athens, Greece), E. Karakou (Athens, Greece), R. Chatzikyriakou (Athens, Greece), N. Trakas (Athens, Greece), X. Tsiafaki (Athens, Greece). Evaluation of Neutrophlil to Lymphocyte Ratio (NLR) in bronchiectasis exacerbation.. 3337

Member's Comments

No comment yet.

Related content which might interest you: Lymphocyte to monocyte ratio (LMR) predicts survival in patients with Idiopathic Pulmonary Fibrosis (IPF). Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Neutrophil/lymphocyte (NLR) ratio in infectious acute exacerbations of COPD (AECOPD) Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Prognostic significance of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Neutrophil CD64 versus Neutrophil/Lymphocyte ratio (NLR) as markers predicting in-hospital outcome in acute exacerbation of COPD Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Response to pulmonary rehabilitation (PR) in bronchiectasis and COPD: a propensity matched analysis Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2017 The difference between surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with chronic obstructive pulmonary disease acute exacerbations (AE COPD) and community acquired pneumonia (CAP) Source: International Congress 2014 – Clinical presentations Year: 2014 Late Breaking Abstract - Frequency Pulmonary embolism (PE) in patients with an acute Exacerbation of chronic obstructive Pulmonary disease (COPD). PEP prospective trial. Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment Year: 2019 Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Apoptosis activated T- lymphocytes in induced sputum (IS) of patients with chronic obstructive bronchitis (COB) Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004 Markers of inflammation and pulmonary function (PF) in sarcoidosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Diagnostic value of CD4/CD8 ratio in induced sputum (IS) in interstitial lung disease (ILD) Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases Year: 2004 Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT® Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012 Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Lung functional decline in patients with Interstitial Pneumonia with Autoimmune Features (IPAF) Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 COPD: Plasma surfactant protein-D (SPD) concentration as a predictor of acute exacerbations (AE) probability Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Chronic obstructive pulmonary disease (COPD) and alterations of hemogram Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020